Additionally, PSMA imaging enables the detection of tumor mass and heterogeneity and together with FDG-PET it might enable proper staging and the early recognition of tumor dedifferentiation to a more aggressive stage [108]. The gene discussed is FOLH1; the disease is neoplasm.